
Novo Nordisk sponsors haemophilia comic
pharmafile | October 7, 2011 | News story | Medical Communications | Novo Nordisk, haemophilia, medical communications news
Novo Nordisk is sponsoring an educational comic about haemophilia for young sufferers of the blood disorder in the UK.
It features the MediKidz, a group of five superheroes from Mediland – a planet shaped like the human body.
The characters are intended to span cultures and appeal across the eight to 15 year old age group to engage with a young audience.
Novo Nordisk’s director of BioPharm Esben Bruun Mortensen said: “The comics are a useful medical educational tool and of genuine value to doctors in their clinical practice. The biggest advantage is to patients as education improves compliance with treatment.”
Produced by medical education publisher MediKidz, the comic will be made available to clinicians in order to help the hundreds of children with haemophilia and rare blood disorders to better understand their condition
Dr Kate Hersov, co-founder of MediKidz, said: “MediKidz is a teaching tool concept adaptable for any medical therapy and provides a unique way of teaching. The company focuses on children and was founded by doctors to explain medical topics in a way they can understand.”
Novo Nordisk currently markets the NovoSeven drug for haemophilia and has a new bleeding disorder agent, NN7415, in Phase I trials for the condition.
Dominic Tyer
Related Content

FDA approves Wegovy for treatment of MASH in adults with liver fibrosis
The US Food and Drug Administration (FDA) has granted accelerated approval for Wegovy (semaglutide) as …

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation
BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of …

Pila Pharma raises SEK 20m to advance new oral obesity treatment
Swedish biotech, Pila Pharma, has raised nearly SEK 20m, equivalent to €1.7m in a capital …






